| Pharmaceutical active ingredients: |
| Natalizumab |
| Available forms, composition and doses of Tysabri: |
| Injectable; Injection; Natalizumab 20 mg / mlInjectable; Injection; Natalizumab 300 mg |
| Tysabri medical category: |
| Human:Humanized monoclonal antibodiesMultiple sclerosis and Crohn's disease treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L04AA23 - Natalizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Biogen IdecElan Pharmaceuticals |
| Related documents and information about Tysabri: |
| Tysabri prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tyrothricine + Gramicidine | Benzethonium Chloride; Gramicidin; Tetracaine Hydrochloride; Tyrothricin | Democal |
| Tyrothricine + Gramicidine Citron | Benzethonium Chloride; Gramicidin; Tetracaine Hydrochloride; Tyrothricin | Democal |
| Tyrothricine + Gramicidine Menthe | Benzethonium Chloride; Gramicidin; Tetracaine Hydrochloride; Tyrothricin | Democal |
| Tyrothricine Lafran | Butamben; Tyrothricin | Lafran Laboratoires |
| Tyrozets | Benzocaine; Tyrothricin | Johnson & Johnson; Merck; Ortho McNeil Pharmaceuticals |
| Tytin | Alcohol; Antipyrine; Benzocaine; Hexylresorcinol; Propylene Glycol; Tyrothricin | Wockhardt |
| Tyvaso | Treprostinil Sodium | United Therapeutics Corporation |
| Tyvax VI Plus | Typhoid Vaccine VI Polysaccharide | VHB Lifesciences; GenBiotech |
| Tyverb | Lapatinib Tosylate | GlaxoSmithKline |
| Tyvid | Isoniazid | Unidentified Pharmaceutical Company |